Logo image of NRDS

NERDWALLET INC-CL A (NRDS) Stock Fundamental Analysis

NASDAQ:NRDS - Nasdaq - US64082B1026 - Common Stock - Currency: USD

8.42  -0.12 (-1.41%)

After market: 8.39 -0.03 (-0.36%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NRDS. NRDS was compared to 53 industry peers in the Consumer Finance industry. While NRDS has a great health rating, its profitability is only average at the moment. NRDS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

NRDS had positive earnings in the past year.
In the past year NRDS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NRDS reported negative net income in multiple years.
In the past 5 years NRDS always reported a positive cash flow from operatings.
NRDS Yearly Net Income VS EBIT VS OCF VS FCFNRDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

NRDS's Return On Assets of 6.95% is amongst the best of the industry. NRDS outperforms 83.02% of its industry peers.
NRDS's Return On Equity of 8.35% is in line compared to the rest of the industry. NRDS outperforms 45.28% of its industry peers.
NRDS has a Return On Invested Capital of 1.97%. This is comparable to the rest of the industry: NRDS outperforms 49.06% of its industry peers.
Industry RankSector Rank
ROA 6.95%
ROE 8.35%
ROIC 1.97%
ROA(3y)0.58%
ROA(5y)-1.57%
ROE(3y)0.72%
ROE(5y)-2.17%
ROIC(3y)N/A
ROIC(5y)N/A
NRDS Yearly ROA, ROE, ROICNRDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

NRDS's Profit Margin of 4.42% is on the low side compared to the rest of the industry. NRDS is outperformed by 71.70% of its industry peers.
NRDS's Profit Margin has declined in the last couple of years.
NRDS's Operating Margin of 1.37% is on the low side compared to the rest of the industry. NRDS is outperformed by 62.26% of its industry peers.
In the last couple of years the Operating Margin of NRDS has declined.
NRDS's Gross Margin of 90.77% is amongst the best of the industry. NRDS outperforms 84.91% of its industry peers.
NRDS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.37%
PM (TTM) 4.42%
GM 90.77%
OM growth 3YN/A
OM growth 5Y-35.7%
PM growth 3YN/A
PM growth 5Y-16.05%
GM growth 3Y-0.63%
GM growth 5Y-0.47%
NRDS Yearly Profit, Operating, Gross MarginsNRDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NRDS is destroying value.
NRDS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, NRDS has more shares outstanding
Compared to 1 year ago, NRDS has a worse debt to assets ratio.
NRDS Yearly Shares OutstandingNRDS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
NRDS Yearly Total Debt VS Total AssetsNRDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 6.61 indicates that NRDS is not in any danger for bankruptcy at the moment.
NRDS's Altman-Z score of 6.61 is amongst the best of the industry. NRDS outperforms 96.23% of its industry peers.
There is no outstanding debt for NRDS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.61
ROIC/WACC0.22
WACC9%
NRDS Yearly LT Debt VS Equity VS FCFNRDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

NRDS has a Current Ratio of 3.27. This indicates that NRDS is financially healthy and has no problem in meeting its short term obligations.
NRDS's Current ratio of 3.27 is fine compared to the rest of the industry. NRDS outperforms 79.25% of its industry peers.
NRDS has a Quick Ratio of 3.27. This indicates that NRDS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.27, NRDS belongs to the best of the industry, outperforming 81.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
NRDS Yearly Current Assets VS Current LiabilitesNRDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

6

3. Growth

3.1 Past

NRDS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 450.00%, which is quite impressive.
NRDS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.81% yearly.
Looking at the last year, NRDS shows a quite strong growth in Revenue. The Revenue has grown by 14.71% in the last year.
The Revenue has been growing by 24.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)450%
EPS 3YN/A
EPS 5Y0.81%
EPS Q2Q%5200%
Revenue 1Y (TTM)14.71%
Revenue growth 3Y21.9%
Revenue growth 5Y24.67%
Sales Q2Q%37.47%

3.2 Future

NRDS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.52% yearly.
Based on estimates for the next years, NRDS will show a small growth in Revenue. The Revenue will grow by 6.39% on average per year.
EPS Next Y-35.95%
EPS Next 2Y16.47%
EPS Next 3Y16.52%
EPS Next 5YN/A
Revenue Next Year12.92%
Revenue Next 2Y10.62%
Revenue Next 3Y8.29%
Revenue Next 5Y6.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NRDS Yearly Revenue VS EstimatesNRDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
NRDS Yearly EPS VS EstimatesNRDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.18, which indicates a rather expensive current valuation of NRDS.
66.04% of the companies in the same industry are cheaper than NRDS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of NRDS to the average of the S&P500 Index (27.63), we can say NRDS is valued slightly cheaper.
The Price/Forward Earnings ratio is 26.83, which means the current valuation is very expensive for NRDS.
NRDS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. NRDS is more expensive than 69.81% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.85. NRDS is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 17.18
Fwd PE 26.83
NRDS Price Earnings VS Forward Price EarningsNRDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NRDS is valued a bit cheaper than 79.25% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRDS indicates a slightly more expensive valuation: NRDS is more expensive than 60.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.42
EV/EBITDA 9.63
NRDS Per share dataNRDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as NRDS's earnings are expected to grow with 16.52% in the coming years.
PEG (NY)N/A
PEG (5Y)21.12
EPS Next 2Y16.47%
EPS Next 3Y16.52%

0

5. Dividend

5.1 Amount

No dividends for NRDS!.
Industry RankSector Rank
Dividend Yield N/A

NERDWALLET INC-CL A

NASDAQ:NRDS (4/21/2025, 8:00:01 PM)

After market: 8.39 -0.03 (-0.36%)

8.42

-0.12 (-1.41%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners83.22%
Inst Owner Change-0.02%
Ins Owners6.28%
Ins Owner Change1.42%
Market Cap627.21M
Analysts81.54
Price Target16.83 (99.88%)
Short Float %5.73%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2342.78%
Min EPS beat(2)168.76%
Max EPS beat(2)4516.81%
EPS beat(4)3
Avg EPS beat(4)1142.77%
Min EPS beat(4)-125.51%
Max EPS beat(4)4516.81%
EPS beat(8)5
Avg EPS beat(8)546.69%
EPS beat(12)7
Avg EPS beat(12)374.71%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)8.73%
Min Revenue beat(2)6.9%
Max Revenue beat(2)10.57%
Revenue beat(4)3
Avg Revenue beat(4)4.23%
Min Revenue beat(4)-1.64%
Max Revenue beat(4)10.57%
Revenue beat(8)5
Avg Revenue beat(8)2.16%
Revenue beat(12)8
Avg Revenue beat(12)2.12%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-227.32%
EPS NY rev (1m)-17.22%
EPS NY rev (3m)-30.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 17.18
Fwd PE 26.83
P/S 0.91
P/FCF 12.42
P/OCF 8.74
P/B 1.72
P/tB 2.87
EV/EBITDA 9.63
EPS(TTM)0.49
EY5.82%
EPS(NY)0.31
Fwd EY3.73%
FCF(TTM)0.68
FCFY8.05%
OCF(TTM)0.96
OCFY11.45%
SpS9.23
BVpS4.89
TBVpS2.93
PEG (NY)N/A
PEG (5Y)21.12
Profitability
Industry RankSector Rank
ROA 6.95%
ROE 8.35%
ROCE 2.49%
ROIC 1.97%
ROICexc 2.4%
ROICexgc 4.55%
OM 1.37%
PM (TTM) 4.42%
GM 90.77%
FCFM 7.34%
ROA(3y)0.58%
ROA(5y)-1.57%
ROE(3y)0.72%
ROE(5y)-2.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-36.98%
ROICexc growth 3YN/A
ROICexc growth 5Y-44.38%
OM growth 3YN/A
OM growth 5Y-35.7%
PM growth 3YN/A
PM growth 5Y-16.05%
GM growth 3Y-0.63%
GM growth 5Y-0.47%
F-Score7
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.01%
Cap/Sales 3.1%
Interest Coverage 31.33
Cash Conversion 124.22%
Profit Quality 166.12%
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z 6.61
F-Score7
WACC9%
ROIC/WACC0.22
Cap/Depr(3y)64.08%
Cap/Depr(5y)80.19%
Cap/Sales(3y)4.66%
Cap/Sales(5y)5.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)450%
EPS 3YN/A
EPS 5Y0.81%
EPS Q2Q%5200%
EPS Next Y-35.95%
EPS Next 2Y16.47%
EPS Next 3Y16.52%
EPS Next 5YN/A
Revenue 1Y (TTM)14.71%
Revenue growth 3Y21.9%
Revenue growth 5Y24.67%
Sales Q2Q%37.47%
Revenue Next Year12.92%
Revenue Next 2Y10.62%
Revenue Next 3Y8.29%
Revenue Next 5Y6.39%
EBIT growth 1Y88%
EBIT growth 3YN/A
EBIT growth 5Y-19.84%
EBIT Next Year3573.72%
EBIT Next 3Y287.17%
EBIT Next 5Y132.81%
FCF growth 1Y18.54%
FCF growth 3YN/A
FCF growth 5Y24.92%
OCF growth 1Y-0.42%
OCF growth 3Y115.24%
OCF growth 5Y17.99%